Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins
Saved in:
Published in | Blood cancer journal (New York) Vol. 11; no. 6; pp. 108 - 6 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
04.06.2021
Springer Nature B.V Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 2044-5385 2044-5385 |
DOI | 10.1038/s41408-021-00499-z |
Cover
ArticleNumber | 108 |
---|---|
Author | Blaeschke, Franziska Apfelbeck, Antonia Feuchtinger, Tobias Willier, Semjon Kaeuferle, Theresa Rataj, Felicitas Kobold, Sebastian Lepenies, Mareike Majzner, Robbie G. Stenger, Dana Benmebarek, Mohamed-Reda Ortner, Eva Busch, Dirk H. Cadilha, Bruno L. Mahdawi, Jasmin Habjan, Nicola |
Author_xml | – sequence: 1 givenname: Franziska surname: Blaeschke fullname: Blaeschke, Franziska organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich – sequence: 2 givenname: Dana surname: Stenger fullname: Stenger, Dana organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, German Cancer Consortium (DKTK), Partner Site Munich – sequence: 3 givenname: Antonia surname: Apfelbeck fullname: Apfelbeck, Antonia organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich – sequence: 4 givenname: Bruno L. surname: Cadilha fullname: Cadilha, Bruno L. organization: Center for Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, LMU Munich – sequence: 5 givenname: Mohamed-Reda surname: Benmebarek fullname: Benmebarek, Mohamed-Reda organization: Center for Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, LMU Munich – sequence: 6 givenname: Jasmin surname: Mahdawi fullname: Mahdawi, Jasmin organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich – sequence: 7 givenname: Eva surname: Ortner fullname: Ortner, Eva organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich – sequence: 8 givenname: Mareike surname: Lepenies fullname: Lepenies, Mareike organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich – sequence: 9 givenname: Nicola surname: Habjan fullname: Habjan, Nicola organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich – sequence: 10 givenname: Felicitas surname: Rataj fullname: Rataj, Felicitas organization: Center for Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, LMU Munich – sequence: 11 givenname: Semjon surname: Willier fullname: Willier, Semjon organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich – sequence: 12 givenname: Theresa surname: Kaeuferle fullname: Kaeuferle, Theresa organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, National Center for Infection Research (DZIF) – sequence: 13 givenname: Robbie G. surname: Majzner fullname: Majzner, Robbie G. organization: Department of Pediatrics, Stanford University School of Medicine, Stanford Cancer Institute, Stanford University School of Medicine – sequence: 14 givenname: Dirk H. orcidid: 0000-0001-8713-093X surname: Busch fullname: Busch, Dirk H. organization: National Center for Infection Research (DZIF), Institute for Medical Microbiology, Immunology and Hygiene, Technical University Munich, Focus Group “Clinical Cell Processing and Purification”, Institute for Advanced Study, TUM – sequence: 15 givenname: Sebastian surname: Kobold fullname: Kobold, Sebastian organization: German Cancer Consortium (DKTK), Partner Site Munich, Center for Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, LMU Munich – sequence: 16 givenname: Tobias orcidid: 0000-0002-8517-9681 surname: Feuchtinger fullname: Feuchtinger, Tobias email: tobias.feuchtinger@med.uni-muenchen.de organization: Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, German Cancer Consortium (DKTK), Partner Site Munich, National Center for Infection Research (DZIF) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34088894$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kk1v1DAQhiNURD_oH-CAInHhEhh_xfYFabWlUKkSCJWz5ThO6iVrL3ZSif56nKYLbQ_1ZfzxvK_GM3NcHPjgbVG8QfABAREfE0UURAUYVQBUyur2RXGEgdKKEcEOHuwPi9OUNpAXq5FE8lVxSLJUCEmPCr2a-q31o_N9qXOo1mdI5l27P2Fcrlc_yqvK2GEou8mb0QVfTmlWfD-r0MyI0lxb82sXnB8zk2ZiF8NonU-vi5edHpI9vY8nxc_zz1frr9Xlty8X69VlZRiFsaKWS2xbzBsqbUOMsEgC0Vi2RHDRGKhxyySWltGm7lpAjAElUCNSS5bfyElxsfi2QW_ULrqtjn9U0E7dXYTYKx1HZwardIc506hhhmtqTKdbqTnS3EitKQDOXp8Wr93UbG1rcoGiHh6ZPn7x7lr14UYJxAUFmQ3e3xvE8HuyaVRbl-YKam_DlBTOjQFGOZvRd0_QTZiiz6WaKQ5Q559m6u3DjP6lsu9kBsQCmBhSirZTxo167lVO0A0KgZrnRi1zo_LcqLu5UbdZip9I9-7PisgiShn2vY3_035G9RfXq9Jj |
CitedBy_id | crossref_primary_10_3389_fimmu_2022_883694 crossref_primary_10_1186_s12943_022_01561_5 crossref_primary_10_3389_fimmu_2023_1063454 crossref_primary_10_1136_jitc_2023_007829 crossref_primary_10_1016_j_blre_2024_101241 crossref_primary_10_3389_fonc_2022_832765 crossref_primary_10_2147_OTT_S274551 crossref_primary_10_1016_j_cell_2023_08_013 crossref_primary_10_1080_2162402X_2022_2163781 crossref_primary_10_1016_j_intimp_2025_114083 crossref_primary_10_3389_fimmu_2023_1265299 crossref_primary_10_1016_j_omton_2024_200815 crossref_primary_10_1007_s13402_022_00747_9 crossref_primary_10_3389_fimmu_2022_845499 crossref_primary_10_1371_journal_pone_0310430 crossref_primary_10_3389_fimmu_2022_869825 crossref_primary_10_1016_j_phrs_2023_107018 crossref_primary_10_1016_j_xcrm_2024_101421 crossref_primary_10_1038_s41392_022_01136_2 crossref_primary_10_1038_s41416_023_02332_9 |
Cites_doi | 10.1158/0008-5472.CAN-15-2524 10.1182/blood-2017-02-769208 10.1158/1078-0432.CCR-20-1457 10.1158/1078-0432.CCR-17-0867 10.1158/1078-0432.CCR-13-0458 10.1182/blood-2004-11-4564 10.1056/NEJMoa1709866 10.1038/s41598-017-00462-8 10.18632/oncotarget.12357 10.1038/nbt.4195 10.1158/1078-0432.CCR-20-2085 10.1038/s41375-020-0793-1 10.3389/fimmu.2018.01955 10.1038/nature24649 10.1093/jnci/djv146 |
ContentType | Journal Article |
Copyright | The Author(s) 2021 The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2021 – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1038/s41408-021-00499-z |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2044-5385 |
EndPage | 6 |
ExternalDocumentID | oai_doaj_org_article_af275a1b5c7a4ccfad9a71a7c9aa4002 PMC8178409 34088894 10_1038_s41408_021_00499_z |
Genre | Letter Research Support, Non-U.S. Gov't Correspondence |
GroupedDBID | 0R~ 3V. 53G 5VS 7X7 88E 8FI 8FJ AAJSJ ABUWG ACGFS ACSMW ADBBV AENEX AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EJD EMOBN FRP FYUFA GROUPED_DOAJ GX1 HMCUK HYE KQ8 M1P M48 M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP W2D AASML AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK AARCD AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c540t-4e792ed27b49eb3c8e1903a29d3878bc062d5929e54b6fd0155043061369562d3 |
IEDL.DBID | M48 |
ISSN | 2044-5385 |
IngestDate | Wed Aug 27 01:31:59 EDT 2025 Thu Aug 21 18:14:57 EDT 2025 Fri Sep 05 12:52:17 EDT 2025 Wed Aug 13 08:18:21 EDT 2025 Mon Jul 21 05:13:57 EDT 2025 Thu Apr 24 23:11:30 EDT 2025 Tue Jul 01 02:32:59 EDT 2025 Fri Feb 21 02:38:29 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c540t-4e792ed27b49eb3c8e1903a29d3878bc062d5929e54b6fd0155043061369562d3 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 content type line 14 ObjectType-Article-2 content type line 23 |
ORCID | 0000-0002-8517-9681 0000-0001-8713-093X |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41408-021-00499-z |
PMID | 34088894 |
PQID | 2537006550 |
PQPubID | 2041967 |
PageCount | 6 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_af275a1b5c7a4ccfad9a71a7c9aa4002 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8178409 proquest_miscellaneous_2538054759 proquest_journals_2537006550 pubmed_primary_34088894 crossref_citationtrail_10_1038_s41408_021_00499_z crossref_primary_10_1038_s41408_021_00499_z springer_journals_10_1038_s41408_021_00499_z |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-06-04 |
PublicationDateYYYYMMDD | 2021-06-04 |
PublicationDate_xml | – month: 06 year: 2021 text: 2021-06-04 day: 04 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: United States |
PublicationTitle | Blood cancer journal (New York) |
PublicationTitleAbbrev | Blood Cancer J |
PublicationTitleAlternate | Blood Cancer J |
PublicationYear | 2021 |
Publisher | Nature Publishing Group UK Springer Nature B.V Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Springer Nature B.V – name: Nature Publishing Group |
References | Zhou (CR15) 2020; 26 Wartewig (CR14) 2017; 552 Rupp (CR13) 2017; 7 Straathof (CR10) 2005; 105 CR6 Rafiq (CR12) 2018; 36 Liu (CR9) 2020; 27 John (CR3) 2013; 19 Blaeschke (CR5) 2020; 34 Rataj (CR7) 2018; 9 Li (CR11) 2017; 23 Maude (CR2) 2018; 378 Feucht (CR4) 2016; 7 Liu (CR8) 2016; 76 Gardner (CR1) 2017; 129 SL Maude (499_CR2) 2018; 378 F Rataj (499_CR7) 2018; 9 T Wartewig (499_CR14) 2017; 552 X Liu (499_CR8) 2016; 76 LB John (499_CR3) 2013; 19 LJ Rupp (499_CR13) 2017; 7 499_CR6 KC Straathof (499_CR10) 2005; 105 KI Zhou (499_CR15) 2020; 26 RA Gardner (499_CR1) 2017; 129 S Rafiq (499_CR12) 2018; 36 S Li (499_CR11) 2017; 23 H Liu (499_CR9) 2020; 27 J Feucht (499_CR4) 2016; 7 F Blaeschke (499_CR5) 2020; 34 |
References_xml | – volume: 76 start-page: 1578 year: 2016 end-page: 1590 ident: CR8 article-title: A chimeric switch-receptor targeting PD1 augments the efficacy of second-generation CAR T cells in advanced solid tumors publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-15-2524 – volume: 129 start-page: 3322 year: 2017 end-page: 3331 ident: CR1 article-title: Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults publication-title: Blood doi: 10.1182/blood-2017-02-769208 – volume: 27 start-page: 473 year: 2020 end-page: 484 ident: CR9 article-title: CD19-specific CAR T cells that express a PD-1/CD28 chimeric switch-receptor are effective in patients with PD-L1-positive B-cell lymphoma publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-20-1457 – volume: 23 start-page: 6982 year: 2017 end-page: 6992 ident: CR11 article-title: Enhanced cancer immunotherapy by chimeric antigen receptor-modified T cells engineered to secrete checkpoint inhibitors publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-17-0867 – volume: 19 start-page: 5636 year: 2013 end-page: 5646 ident: CR3 article-title: Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-13-0458 – volume: 105 start-page: 4247 year: 2005 end-page: 4254 ident: CR10 article-title: An inducible caspase 9 safety switch for T-cell therapy publication-title: Blood doi: 10.1182/blood-2004-11-4564 – volume: 378 start-page: 439 year: 2018 end-page: 448 ident: CR2 article-title: Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia publication-title: N. Engl J. Med. doi: 10.1056/NEJMoa1709866 – volume: 7 year: 2017 ident: CR13 article-title: CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells publication-title: Sci. Rep. doi: 10.1038/s41598-017-00462-8 – volume: 7 start-page: 76902 year: 2016 end-page: 76919 ident: CR4 article-title: T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts publication-title: Oncotarget doi: 10.18632/oncotarget.12357 – volume: 36 start-page: 847 year: 2018 end-page: 856 ident: CR12 article-title: Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo publication-title: Nat. Biotechnol. doi: 10.1038/nbt.4195 – volume: 26 start-page: 6453 year: 2020 end-page: 6463 ident: CR15 article-title: Spatial and temporal heterogeneity of PD-L1 expression and tumor mutational burden in gastroesophageal adenocarcinoma at baseline diagnosis and after chemotherapy publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-20-2085 – ident: CR6 – volume: 34 start-page: 2607 year: 2020 end-page: 2620 ident: CR5 article-title: Leukemia-induced dysfunctional TIM-3(+)CD4(+) bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patients publication-title: Leukemia doi: 10.1038/s41375-020-0793-1 – volume: 9 start-page: 1955 year: 2018 ident: CR7 article-title: PD1-CD28 fusion protein enables CD4+ T cell help for adoptive T cell therapy in models of pancreatic cancer and non-hodgkin lymphoma publication-title: Front. Immunol. doi: 10.3389/fimmu.2018.01955 – volume: 552 start-page: 121 year: 2017 end-page: 125 ident: CR14 article-title: PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis publication-title: Nature doi: 10.1038/nature24649 – volume: 105 start-page: 4247 year: 2005 ident: 499_CR10 publication-title: Blood doi: 10.1182/blood-2004-11-4564 – volume: 26 start-page: 6453 year: 2020 ident: 499_CR15 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-20-2085 – volume: 27 start-page: 473 year: 2020 ident: 499_CR9 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-20-1457 – volume: 7 year: 2017 ident: 499_CR13 publication-title: Sci. Rep. doi: 10.1038/s41598-017-00462-8 – volume: 378 start-page: 439 year: 2018 ident: 499_CR2 publication-title: N. Engl J. Med. doi: 10.1056/NEJMoa1709866 – volume: 76 start-page: 1578 year: 2016 ident: 499_CR8 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-15-2524 – volume: 552 start-page: 121 year: 2017 ident: 499_CR14 publication-title: Nature doi: 10.1038/nature24649 – ident: 499_CR6 doi: 10.1093/jnci/djv146 – volume: 34 start-page: 2607 year: 2020 ident: 499_CR5 publication-title: Leukemia doi: 10.1038/s41375-020-0793-1 – volume: 7 start-page: 76902 year: 2016 ident: 499_CR4 publication-title: Oncotarget doi: 10.18632/oncotarget.12357 – volume: 129 start-page: 3322 year: 2017 ident: 499_CR1 publication-title: Blood doi: 10.1182/blood-2017-02-769208 – volume: 9 start-page: 1955 year: 2018 ident: 499_CR7 publication-title: Front. Immunol. doi: 10.3389/fimmu.2018.01955 – volume: 36 start-page: 847 year: 2018 ident: 499_CR12 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.4195 – volume: 23 start-page: 6982 year: 2017 ident: 499_CR11 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-17-0867 – volume: 19 start-page: 5636 year: 2013 ident: 499_CR3 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-13-0458 |
SSID | ssj0000561919 |
Score | 2.3364456 |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 108 |
SubjectTerms | 13/31 13/44 631/250/251 631/67/1990/283/2125 692/699/1541/1990/283/2125 Antigens, CD19 - immunology Biomedical and Life Sciences Biomedicine Cancer Research CD28 Antigens - therapeutic use Cell Line, Tumor Correspondence Hematology Humans Immunotherapy, Adoptive Oncology Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - immunology Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy Programmed Cell Death 1 Receptor - therapeutic use Receptors, IgE - immunology Recombinant Fusion Proteins - pharmacology |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hHhAXxJtAQUbiBlbjV2wft1uqCqkIoVbqzXJsZ1lRZSt299Jf37GTXbo8L9ySeCKN5qH5Jp58BnirvMiVUVKluKWy7Txt2yZQrI2Bp6BYLDzbp5-ak3P58UJd3DrqK8-EDfTAg-EOfMe18qxVQXsZQuej9Zp5Haz3cqSRrG19q5kaWL2xMWB2_EumFuZgKbGVMDRPJBSYT693KlEh7P8dyvx1WPKnHdNSiI4fwP0RQZLJoPlDuJP6R3D3dNwjfwx-sp6VGaB-RtBsczo9Yhav4uaOczKdfCFnNH-0J7mwZeeQPAE_I5-PsNtDGUPQm-Hb1WLer1Amf1MjhdNh3i-fwPnxh7PpCR0PUqABAdmKyqQtT5HrVlpsnoNJCAOE5zYKo00b6oZHhTgpKdk2XSxtixS50jfYPvEonsJev-jTcyCyDYF1koXOaNn54BUCoKSFtil6k7oK2MaoLows4_mwi0tXdruFcYMjHDrCFUe46wrebd-5Gjg2_ip9mH21lcz82OUBRo0bo8b9K2oq2N942o1Ju3RcCZ0hmaoreLNdxnTL7vB9WqyLjEGUq5Wt4NkQGFtNBGpqjJUV6J2Q2VF1d6Wffy2U3obp3GlX8H4TXD_U-rMpXvwPU7yEe7xkRUNruQ97q-_r9AqB1qp9XXLqBtUbImE priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxELagSIgL4s1CQUbiBlbj19o-oZBSVUhFCLVSbpbX9oYItBua5NJfz9jxbhUevW3WE8nxN_Z8M57MIPRWOp4soyBSMkNE0zrSNLUnYBs9i17SkOtsn32pTy_E57mcl4DbuqRVDmdiPqhD71OM_IhJrpK9lJMPq18kdY1Kt6ulhcZtdIcCE0mtG9RcjTGWxI4NNeW_MhOuj9YCHApNUl5CJvvkas8e5bL9_-Kaf6dM_nFvms3RyQN0v_BIPN0B_xDdit0jdPes3JQ_Rm66XeRMoG6BYfGWZHZMDTyF4RNjeDb9hs9JCt3jZN4SRDjlwS_w12Pw-UBGY8DU_1j1y24DMimyhnNlh2W3foIuTj6dz05JaadAPNCyDRFRGRYDU40w4EJ7HYEMcMdM4Frpxk9qFiSwpShFU7chOy-CJ3tfgxPFAn-KDrq-i88RFo33tBXUt1qJ1nkngQZFxZWJwenYVogOi2p9qTWeWl78tPnOm2u7A8ICEDYDYa8q9G78zmpXaeNG6Y8Jq1EyVcnOL_rLhS2bzrqWKeloI71ywvvWBeMUdcob5-DsYhU6HJC2Zeuu7bWiVejNOAybLsHhuthvs4wGrqukqdCznWKMM-EwU62NqJDaU5m9qe6PdMvvubC3pir52xV6PyjX9bT-vxQvbv4VL9E9lvW9JhNxiA42l9v4CojUpnmdd8tv3GMYXQ priority: 102 providerName: ProQuest – databaseName: Springer Nature HAS Fully OA dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEB9qC-KL-O1qlQi-afA2H5vkcb1aykFFtIW-hSSbvR7KXundvfSvd5LbXTmtgm-7m1kYMpPMb5LJLwBvpeMpMgoqJTNU-NZR76tAMTYGFoMsm8yzffq5OjkXswt5sQdsOAuTi_YzpWWepofqsA8rgZmApqmgIKN0enMHDrTiFQ7Gg7qefZuNKysJE5vS9CdkJlzf8vNOFMpk_bchzD8LJX_bLc1B6PgB3O_RI6m3-j6Evdg9grun_f74Y3D1Zp7rf7o5wS5b0OlRafCpGd4YI9P6KzmjacGepKCWDENS9fucfDnCTA9lNEFLhu9Xy0W3Rpm0nkYyn8OiWz2B8-NPZ9MT2l-iQAOCsTUVURkWG6a8MJg4Bx0RAnDHTMO10j5MKtZIxEhRCl-1TU5ZBE9RvsLUiTX8Kex3yy4-ByJ8CGUrytBqJVoXnETwExVXJjZOx7aAcuhUG3qG8XTRxQ-bd7q5tltDWDSEzYawNwW8G_-52vJr_FP6Y7LVKJm4sfOH5fXc9r5iXcuUdKWXQTkRQusa41TpVDDO4YzFCjgcLG37AbuyTHKV4JicFPBmbMahlszhurjcZBmNCFdJU8CzrWOMmnDUVGsjClA7LrOj6m5Lt7jMdN66VCnLLuD94Fy_1Pp7V7z4P_GXcI9l_6_oRBzC_vp6E18hnFr71_34-QmrHBgb priority: 102 providerName: Springer Nature |
Title | Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins |
URI | https://link.springer.com/article/10.1038/s41408-021-00499-z https://www.ncbi.nlm.nih.gov/pubmed/34088894 https://www.proquest.com/docview/2537006550 https://www.proquest.com/docview/2538054759 https://pubmed.ncbi.nlm.nih.gov/PMC8178409 https://doaj.org/article/af275a1b5c7a4ccfad9a71a7c9aa4002 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB71IVW9IN6klFWQuIFh49ixfUAoTVuqlVpVpSvtLXIcZ1lRZdt9SNBfz9hJFi0sHLjkYY8VyzOT-cYejwHecB07y8gI51QRVlSaFEViCNpGQ63hUenzbJ9fJGdDNhjx0RZ0xx21Azjf6Nq586SGs5v33-9-fEKF_9hsGZcf5gy9BElcsIFH8OR-G3b9epEL5WvhfpPrG92FSLV7ZzY33Ye9GIukVGzNVPmM_ptg6J_RlL8tqXpLdfoQHrQQM0wbmXgEW7Z-DHvn7SL6E9DpcuyDhOpxiOM6IdlxpPCp7N4oDbP0KrwmblY_dJbPcS90IfLj8PIY3UGkkSGy23y7nU7qBdK4SbfQJ32Y1POnMDw9uc7OSHvSAjGI2BaEWaGoLakomELv2kiLOCHWVJWxFLIw_YSWHIGU5axIqtL7NSx2UCBB_4qW8TPYqae1fQEhK4yJKhaZSgpWaaM5IiQrYqFsqaWtAoi6Qc1Nm4bcnYZxk_vl8FjmDU9y5EnueZLfB_B21ea2ScLxT-ojx6sVpUug7Qums3He6mOuKyq4jgpuhGbGVLpUWkRaGKU1_tZoAIcdp_NOKHPKY-EwG-8H8HpVjfro2KFrO116GokwWHAVwPNGMFY96QQrALEmMmtdXa-pJ199zm8ZCeeKB_CuE65f3fr7UBz894dewj71WpGQPjuEncVsaV8h_FoUPdgWI9GD3TQdfBng_ejk4vIKS7Mk6_kpDbx-HkU9r3s_AdvzMBE |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgJeEN8EBgQJnsBa49ix_TChrt20sbWapk7aW3Bsp1SgtKytEPvj-Ns4u0mn8rG3vSXxJXJ8Z9_vfOc7gLdcp14zMsI5VYQVpSZFkRmCutFQZ3hiQ57t_iA7OGOfzvn5BvxqzsL4sMpmTQwLtZ0Yv0e-TXkqvL7k7Y_T78RXjfLe1aaEhq5LK9idkGKsPthx5H7-QBNutnPYQ36_o3R_b9g9IHWVAWIQrcwJc0JRZ6komELL0kiHOjLVVNlUClmYdkYtRxDhOCuy0gZMz1KvBjO0LahN8bu3YJP5DZQWbO7uDU5OV7s8Hp-rRNWnddqp3J4xNGkk8ZERwdwgl2saMRQO-Bfa_Tto8w_PbVCI-_fhXo1k485S9B7Ahqsewu1-7at_BLqzGIVYpGoUI_vGpNtLFF7Z5o7SuNs5jYfEOw9ir2C9kMQ-En8Un_TQ6kQaGaNUma_TybiaI43f24tDbolxNXsMZzcy1E-gVU0q9wxiVhiTlCwxpRSs1EZzBGJOpEI5q6UrI0iaQc1Nne3cF934lgeveyrzJSNyZEQeGJFfRvB-9c50mevjWupdz6sVpc_THR5MLkZ5Pe1zXVLBdVJwIzQzptRWaZFoYZTWuHrSCLYaTuf14jHLr0Q9gjerZpz2nh26cpNFoJGItgVXETxdCsaqJyn2VErFIhBrIrPW1fWWavwlpBaXifAWfwQfGuG66tb_h-L59X_xGu4cDPvH-fHh4OgF3KVB9jPSZlvQml8s3EuEdfPiVT13Yvh809P1NxQ2WXU |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NIU28IL4JDDASPIHVxh-x_YBQaak2xqYJbVLfguM4pQKlZW2F2J_GX8fZTTqVj73tLR-XyPHd-Xfnu9wBvJCWB2QUVEpmqCgqS4sicxSx0THvZFrGOtuHR9neqfgwkqMt-NX-CxPSKts1MS7U5dSFPfIOk1wFvJTdTtWkRRwPhm9n32noIBUirW07jZWIHPifP9B9m7_ZHyCvXzI2fH_S36NNhwHq0FJZUOGVYb5kqhAGvUqnPeIjt8yUXCtduG7GSokGhJeiyKoy2vOCBwjM0K9gJcf3XoPriiOsoy6pkVrv7wTL3KSm-U-ny3VnLtCZ0TTkRERHg55vYGFsGfAvO_fvdM0_YrYRCoe34GZjw5LeSuhuw5av78DOYROlvwu2txzHLKR6TJBxE9ofpAaPyvaMMdLvfSInNIQNSIDWIB4k5OCPyfEA_U2k0QTlyX2dTSf1AmnCrh6JVSUm9fwenF7JRN-H7Xpa-4dAROFcWonUVVqJyjor0QTziivjS6t9lUDaTmrumjrnod3GtzzG27nOV4zIkRF5ZER-nsCr9TOzVZWPS6nfBV6tKUOF7nhhejbOG4XPbcWUtGkhnbLCucqWxqrUKmesxXWTJbDbcjpvlo15fiHkCTxf30aFD-ywtZ8uI41GO1tJk8CDlWCsR8JxpFobkYDaEJmNoW7eqSdfYlFxnarg6yfwuhWui2H9fyoeXf4Vz2AHlTT_uH908BhusCj6Ge2KXdhenC39E7TnFsXTqDgEPl-1pv4GqsZXGQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Augmenting+anti-CD19+and+anti-CD22+CAR+T-cell+function+using+PD-1-CD28+checkpoint+fusion+proteins&rft.jtitle=Blood+cancer+journal+%28New+York%29&rft.au=Blaeschke%2C+Franziska&rft.au=Stenger%2C+Dana&rft.au=Apfelbeck%2C+Antonia&rft.au=Cadilha%2C+Bruno+L.&rft.date=2021-06-04&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2044-5385&rft.volume=11&rft.issue=6&rft_id=info:doi/10.1038%2Fs41408-021-00499-z&rft_id=info%3Apmid%2F34088894&rft.externalDocID=PMC8178409 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2044-5385&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2044-5385&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2044-5385&client=summon |